Table 2. Chlorogenic acid modulates pain and inflammation in vivo in rodent models.
Compound | Method | Model | Dose | Response | Refs. | |
---|---|---|---|---|---|---|
Anti-inflammatory effects | CGA | Piroxicam (NSAID)-induced ulcer | Rats | 5, 25, and 50 mg/kg | Gastroprotective effect without altering the secretory functions; inhibited neutrophil migration; restored levels of antioxidant enzymes; blocked increase in TNF-α and leukotriene β4; did not restore prostaglandin levels | [148] |
CGA | Acetaminophen-induced hepatotoxicity | Mice | 10, 20, and 40 mg/kg | Reduced acetaminophen-induced TLR-3/4 and MyD88 expression; attenuated serum levels and liver mRNA expression of TNF-α, IL-1β, and IL-6 | [43] | |
CGA | LPS-induced inflammation | Mice | 50 mg/kg | Decreased neutrophil infiltration in the liver; modulated TLR-4, TNF-α, and NF-κB signaling | [44] | |
Pain modulatory effects | CGA | CCI | Rats | 0.5, 1, and 2 mg in 10 μL | Reduced mechanical and cold hyperalgesia; no effect on thermal hyperalgesia | [96] |
CGA | Streptozotocin-induced diabetic neuropathy | Rats | 100 mg/kg | Antihyperalgesic; chronic treatment reduced diabetes-induced hyperalgesia | [94] | |
CGA | CCI | Rats | 50, 100, and 200 mg/kg | Inhibited mechanical hyperalgesia; antihyperalgesic activity without impairing motor coordination | [95] | |
CGA | Carrageenan-induced paw edema, formalin test | Rats | 10, 50, and 100 mg/kg | Anti-inflammatory and anti-nociceptive | [17] | |
Caffeic acid | Carrageenan-induced inflammation | Mice and Rats | 200 mg/kg | Antihyperalgesic; reduced neutrophil-, free radical-, and nitric oxide-mediated hypernociception | [114] | |
Ferulic acid | CCI | Rats | 50 mg/kg | Antihyperalgesic; decreased P2X3 receptor-mediated primary afferent sensitization | [115] | |
CGA isolated from aqueous fraction of Bidens pilosa | LPS-induced knee joint inflammation, CFA-induced arthritis |
Rats | 2.5, 5, 10, 20, and 40 mg/kg | Anti-inflammatory; inhibited TNF-α and IL-1β production | [97] | |
Methanol fraction of Cheilanthes farinose | Carrageenan-induced inflammation, formalin test, tail-flick test | Mice | 200 and 400 mg/kg | Strong anti-inflammatory and antinociceptive | [24] | |
Cnidium officinale extracts |
Spared nerve injury, plantar incision, and ovariectomy rat model of menopausal pain | Rats | 30, 100, and 300 mg/kg | Antihyperalgesic; attenuated hypersensitivity in all pain models; decreased mechanical hyperalgesia; inhibited proinflammatory cytokines and calpain-3 in dorsal root ganglia neurons |
[91] | |
Mansoa alliacea extract | CFA-induced inflammatory pain model | Mice | 10 and 100 mg/kg | Antihyperalgesic and antinociceptive; reversed thermal hyperalgesia, but did not reduce the CFA-induced edema nor myeloperoxidase activity | [93] | |
Ethanolic fraction of Urtica circularis |
Formalin test, hot plate test, acetic acid stretch test | Mice | 10–300 mg/kg (intraperitoneal) 250 mg/kg and 500 mg/kg (per os) | Antinociceptive in the acid stretch test and formalin test | [20] |